Inotiv reports first quarter financial results for fiscal 2024 and provides business update

- first quarter fiscal 2024 revenue up 10.3% to $135.5 million - first quarter fiscal 2024 dsa revenue up 8.8% to $44.7 million and rms revenue up 11.1% to $90.8 million - shift to a renewed focus on sales and marketing as near-term infrastructure projects near completion - conference call begins today at 4:30 pm et west lafayette, ind., feb. 07, 2024 (globe newswire) -- inotiv, inc. (nasdaq: notv) (the “company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“q1 fy 2024”) ended december 31, 2023.
NOTV Ratings Summary
NOTV Quant Ranking